#NeuroHealing

[southwestpainreliefclinic]

Heal Brain Injuries Naturally with Light Therapy

Discover the power of light therapy in Treating Concussion and Traumatic Brain Injury (TBI). This innovative, non-invasive approach uses red and near-infrared light to reduce inflammation, stimulate cellular repair, and enhance cognitive function. Supported by clinical research and expert insights, light therapy is emerging as a safe and effective solution for patients experiencing symptoms like memory loss, brain fog, and mood changes. Whether you’re exploring alternatives to traditional treatments or seeking long-term relief, this cutting-edge therapy offers new hope for brain recovery and overall neurological health.

[biotechscientist]

Neural Stem Cells: Stroke Recovery Breakthrough! #sciencefather #NeuralStemCells

Neural stem cells possess the unique ability to differentiate into various neural cell types, including neurons, astrocytes, and oligodendrocytes. This versatility enables them to replace damaged or lost neural tissue, facilitating brain repair and functional recovery following a stroke. Moreover, NSCs secrete neurotrophic factors and regulate neuroinflammation, supporting the survival and function of existing neurons and creating a favorable environment for neuroprotection and repair. Visit Our Website : http://biotechnologyscientist.com Contact Us : support@biotechnologyscientist.com Nomination Link : https://biotechnologyscientist.com/award-nomination/?ecategory=Awards&rcategory=Awardee #NeuralStemCells#StrokeRecovery#StemCellTherapy#Neuroregeneration #BrainRepair#Neuroplasticity#RegenerativeMedicine#Neurogenesis #strokerehabilitation #NSCTherapy#Neuroscience#MedicalBreakthrough #BrainHealth#InnovativeMedicine#neuroscienceresearch #StemCellResearch#NeuroRecovery#FutureOfMedicine#NeuroHealing #StrokeAwareness

[aqadaptivenadzen1]

NEUROHEALING • Membership BUNDLE - with Gabriel

[healthcarehubhh]

Body Temperature Monitoring Market Will Grow At Highest Pace Owing To Rising Occurrences Of Fever Cases

The body temperature monitoring market comprises a wide range of thermometers that help in measuring the body temperature of humans and animals. These devices play a crucial role in detecting various health conditions like fever, hyperthermia, hypothermia, and others. Traditional mercury-in-glass and digital thermometers have existed in this market for a long time. However, novel temperature monitoring devices with advanced features like infrared thermometers, smart baby monitors, wearable patches, continuous temperature monitors etc. are gaining widespread popularity. Rising occurrences of fever and infections due to changing lifestyles and growing awareness about preventive healthcare are generating a significant demand for such temperature monitoring solutions. The Global body temperature monitoring market is estimated to be valued at US$ 1.5 Bn in 2024 and is expected to exhibit a CAGR of 8.7% over the forecast period 2023 to 2030. Key Takeaways Key players operating in the body temperature monitoring are Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd. These players are focusing on new product launches and technological advancements to cater to the unmet needs of users. The rising cases of fever and infectious diseases have boosted the demand for easy-to-use, precision thermometers globally. Self-monitoring devices for temperature measurement are gaining popularity due to the flexibility and convenience offered. Moreover, growing awareness about preventive healthcare practices through campaigns is compelling people to frequently check body temperatures. Technological innovations are revolutionizing the temperature monitoring space with the introduction of smart devices, contactless solutions, integrated sensors, connected applications, and artificial intelligence. Continuous temperature monitoring patches, infrared scanning devices, digital baby monitors with advanced data tracking, blue tooth-enabled wearables are some such innovations transforming user experience. Market Trends 1. Growing Adoption of Non-Contact Infrared Thermometers: Non-contact infrared thermometers allow measuring temperature from a distance without any physical contact, thus reducing infection transmission risks. This trend is driving several companies to launch advanced infrared thermometer models. 2. Integration of AI and IoT in Temperature Trackers: Latest smart thermometers are being integrated with AI technologies and internet connectivity. These devices can send alerts, record health data with timestamps and allow teleconsultations with doctors. Market Opportunities 1. Emerging Economies: Developing nations in Asia Pacific and Latin America regions are expected to offer lucrative opportunities for players due to rising medical budgets, increasing per capita income and growing health awareness. 2. Pediatric Monitoring Solutions: Technological innovations in baby thermometers, integration of sensors in diapers/clothing to enable continuous temperature monitoring are expanding opportunities in pediatric healthcare. .

[journalgen]

Advances in Protoepistemology and Neurohate

[globalinsightsservices]

Premature Ejaculation – Drug Pipeline and Companies Insight Report, 2023 Updates: Analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments

As per Global Insight services’ assessment, about 20+ prominent pharma and biotech giants are working on 20+ drugs in the Premature Ejaculation – Drug Pipeline Landscape, 2023 globally. Premature Ejaculation – Drug Pipeline Landscape, 2023 report by Global Insight Services provides a comprehensive analysis of the ongoing clinical development activities and growth prospect.

"Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key –here:https://www.globalinsightservices.com/request-sample/GIS31231

Premature ejaculation is a type of sexual dysfunction that occurs when a man has an orgasm and ejaculates semen sooner than he or his partner would like. It often happens before or shortly after penetration during intercourse.

There are four types of ejaculation dysfunction one is premature ejaculation two delayed ejaculation three retrograde ejaculation and four Anejaculation

The most common causes of premature ejaculation include early sexual experiences and depression. Other factors include erectile dysfunction and anxiety.

Premature ejaculation patients may experience symptoms like a hormonal problem with oxytocin levels,. Abnormal hormone levels that play a role in sexual function include luteinizing hormone (LH), prolactin and thyroid stimulating hormone (TSH) and low serotonin or dopamine levels.

Free customization available - https://www.globalinsightservices.com/request-customization/GIS31231/

Healthcare provider may take a physical exam. If patient experiences early ejaculation and trouble getting or keeping an erection, healthcare provider might order blood tests to check hormone levels.

There are several treatment options for premature ejaculation depending on the cause of the disease which includes behavioral therapy, counseling and medications that includes anti-depressants, analygics and anaesthetics.

Major pharmaceutical companies are involved in the development of potential drug candidates to improve the Premature Ejaculation treatment such as CDFR0812, Fortacin, IX-01 and others. Key players involved in the development of therapies to treat tuberculosis are CTC Bio Inc, Fosun Pharma, Ixchelsis Limited, Neurohealing Pharmaceuticals Inc and others. Two drugs are under late-stage Phase III clinical trials and one drugs are in Phase II clinical trials and some other drugs are under Phase I, preclinical and discovery stages of development.

Buy your copy now: https://www.globalinsightservices.com/checkout/single_user/GIS31231

Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like –

- Late-stage products (Phase III) - Mid-stage products (Phase II) - Early-stage product (Phase I) - Pre-clinical and Discovery stage candidates - Discontinued & Inactive candidates

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

Contact Us:

Global Insight Services LLC 16192, Coastal Highway, Lewes DE 19958 E-mail: info@globalinsightservices.com Phone: +1–833–761–1700 Website: https://www.globalinsightservices.com/

[sharvaricmi]

Neuropathic Pain Market Size, Revenue, Business Growth Statistics And Analysis Report 2019 – 2027

If your nerve system is injured or not functioning properly, you may have neuropathic pain. Pain can be felt at any level of the neurological system, including the peripheral nerves, spinal cord, and brain. The central nervous system is made up of the spinal cord and the brain.

Over the projected period, the worldwide Neuropathic Pain Market Analysis is predicted to rise due to the high frequency of cancer. R&D in the field of neuropathic pain is likely to provide attractive development prospects for market participants. For example, in May 2020, researchers from the University Medical Center Hamburg-Eppendorf and other prestigious German universities reported that loss of C-fiber in Schwannomatosis, a type of neurofibromatosis caused by the occurrence of multiple schwannomas, tumours that develop from Schwann cells, may lead to neuropathic pain.

Market Trends:

Various investigations are being conducted in order to discover non-drug treatments for neuropathic pain. Pomegranate and secondary metabolites, for example, were shown to be useful in the treatment of inflammatory, nociceptive, and neuropathic pain by researchers at the Autonomous University of the State of Hidalgo in Mexico in March 2020.

Combination treatments are becoming increasingly popular in the treatment of neuropathic pain on the market. NeuroHeal, a combination of two repurposed drugs: Acamprosate and Ribavirin, for example, was announced in March 2020 by researchers from the Universitat Autnoma de Barcelona, Spain, to minimise the emergence of neuropathic pain in peripheral nerve damage.

Read more @ https://cmiaspireblog.blogspot.com/2021/12/neuropathic-pain-market-size-share-top.html

Source Links:

https://www.globenewswire.com/en/news-release/2020/05/25/2038154/0/en/Neuropathic-Pain-Market-to-reach-US-9-862-3-Million-globally-by-2027-Coherent-Market-Insights.html

https://www.medgadget.com/2021/05/neuropathic-pain-market-report-2021-to-register-a-cagr-of-6-4-to-reach-us-9862-3-million-by-2027-global-industry-analysis-growth-size-companies-revenue.html

[ivyandink]

“Well, everything changed after Neurohance...”

Previous | Next | Beginning

[epicmeetsfail]

We fed game characters into a ‘neural net' and it told us who they were with an astonishing 15% accuracy https://ift.tt/2LYiBux

Those of you chained to the churning wheel of the internet might have seen this facial recognition algorithm thingo doing the rounds. It’s called ImageNet Roulette, and it’s basically a website where you feed in a photo of your human face and see what the cybergods of our terrible future make of you. But it’s probably not safe to show the neurohive your real face. So we showed it 13 pictures of videogame characters instead, to see if the machine lords of the net realm can tell who they are and what they are all about. The short answer: not really, but sometimes. The neural net, it turns out, is a dangerous idiot.

(more…)

September 16, 2019 at 10:36AM

[ttalgifairy-blog]

Premature Ejaculation Treatment Market Enhancement in Medical Sector 2018 to 2026

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

The global Premature Ejaculation Treatment Market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Competitive Landscape

Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1956

[dreddymd]

Tweeted

RT @theneurohacker: What can heart rate and cortisol tell us about how our bodies are adapting to stress? @mollymaloofmd explains. Want to hear more on the topic? We thought so. Click here > https://t.co/rknzxndEaB#health #collcetiveinsights #neuroh… pic.twitter.com/3iI639YXCr

— Eddy Bettermann 🇩🇪 (@DrEddyMD) April 22, 2018

[cherylrhutcherson]

Global Traumatic Brain Injury Therapeutics Market to Exhibit Impressive Growth During 2018-2025

This report studies the global market size of Traumatic Brain Injury Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Traumatic Brain Injury Therapeutics in these regions.

This research report categorizes the global Traumatic Brain Injury Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter’s Five Forces Analysis.

Request a Sample of this Report@ https://www.orbisresearch.com/contacts/request-sample/2314154

In 2017, the global Traumatic Brain Injury Therapeutics market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Traumatic Brain Injury Therapeutics market based on company, product type, application and key regions.

The various contributors involved in the value chain of Traumatic Brain Injury Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in the Traumatic Brain Injury Therapeutics include

SFC Fluidics LLC

Banayan Biomarkers Inc.

BHR Pharma LLC

Cerora Inc.

ElMindA Ltd.

Grace Laboratories LLC

KeyNeurotek Pharmaceuticals AG

Luoxis Diagnostics

Neuro Assessment Systems

Neurovive Pharmaceuticals AB

Oxygen Biotherapeutics Inc.

Phlogistix LLC

Neurohealing Pharmaceuticals

Neuren Pharmaceuticals Ltd.

Remedy Pharmaceuticals Inc.

Biodirection Inc.

Brainscope Company Inc.

TEVA Pharmaceutical Industries Ltd.

Vasopharm

Market Size Split by Type

Acetylcholinesterase Inhibitors

Erythropoietin

Growth Hormone

Stem Cells

Others

Market Size Split by Application

Focal TBI

Open TBI

Closed TBI

Diffuse TBI

Primary TBI

Others

Market size split by Region

North America

United States

Canada

Mexico

Asia-Pacific

China

India

Japan

South Korea

Australia

Indonesia

Singapore

Malaysia

Philippines

Thailand

Vietnam

Europe

Germany

France

UK

Italy

Spain

Russia

Central & South America

Brazil

Rest of Central & South America

Middle East & Africa

GCC Countries

Turkey

Egypt

South Africa

To make an enquiry on report@ https://www.orbisresearch.com/contacts/enquiry-before-buying/2314154

Some Point from Table of Content:

Chapter One: Study Coverage

1.1 Traumatic Brain Injury Therapeutics Product

1.2 Key Market Segments

1.3 Key Manufacturers Covered

1.4 Market by Type

1.4.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Type

1.4.2 Acetylcholinesterase Inhibitors

1.4.3 Erythropoietin

1.4.4 Growth Hormone

1.4.5 Stem Cells

1.4.6 Others

1.5 Market by Application

1.5.1 Global Traumatic Brain Injury Therapeutics Market Size Growth Rate by Application

1.5.2 Focal TBI

1.5.3 Open TBI

1.5.4 Closed TBI

1.5.5 Diffuse TBI

1.5.6 Primary TBI

1.5.7 Others

1.6 Study Objectives

1.7 Years Considered

Chapter Two: Executive Summary

2.1 Global Traumatic Brain Injury Therapeutics Market Size

2.1.1 Global Traumatic Brain Injury Therapeutics Revenue 2016-2025

2.1.2 Global Traumatic Brain Injury Therapeutics Sales 2016-2025

2.2 Traumatic Brain Injury Therapeutics Growth Rate by Regions

2.2.1 Global Traumatic Brain Injury Therapeutics Sales by Regions

2.2.2 Global Traumatic Brain Injury Therapeutics Revenue by Regions

Browse full report@ https://www.orbisresearch.com/reports/index/global-traumatic-brain-injury-therapeutics-market-insights-forecast-to-2025

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Us:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No: +1 (214) 884-6817; +912064101019

Email ID: sales@orbisresearch.com

[expertofmarketinsights-blog]

Premature Ejaculation Treatment Market To Register Unwavering Growth by 2026

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

The global Premature Ejaculation Treatment Market size was valued at US$ 1.5 Bn in 2017, and is expected to witness a CAGR of 8.7% over the forecast period (2018 – 2026).

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive growth of the market

Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.

Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth

Key players in the market are involved in strategic collaborations for the development of premature ejaculation treatment drugs. For instance, in 2012, Ampio Pharmaceuticals, Inc. entered in a strategic agreement with Ethypharm S.A. for the manufacturing of Zertane, Ampio's drug indicated for the treatment of premature ejaculation. In 2013, Absorption Pharmaceuticals LLC entered into a strategic collaboration with Kaiser Permanente for initiating clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation (PE). Such strategic collaborations by key players for the development, manufacturing, and evaluation of novel drugs is expected to fuel the global premature ejaculation treatment market growth.

Competitive Landscape

Key players operating in the premature ejaculation treatment market include Regent Pacific Group Limited, Menarini Group, Furiex Pharmaceuticals, Inc., Absorption Pharmaceuticals, LLC, Ampio Pharmaceuticals, Inc., Aytu BioScience, NeuroHealing Pharmaceuticals Inc., and Dong-A Pharmaceutical Co., Ltd.

Ask For Sample Copy Of This Business Research Report : https://www.coherentmarketinsights.com/insight/request-sample/1956

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

Global Premature Ejaculation Treatment Market, By Route of Administration:

Oral

Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:

Pills

Spray

Others

Global Premature Ejaculation Treatment Market, By Distribution Channel:

Hospitals

Online Pharmacies

Retail Pharmacies

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

[sumit76652-blog]

Premature Ejaculation Treatment Market - Global Forecast to 2026

Premature ejaculation also called as rapid ejaculation, premature climax or early ejaculation. It is a disorder, which causes early ejaculation of semen during sexual intercourse. Premature ejaculation is a very common problem, and its exact cause is not known. However, causes include early sexual experiences, sexual abuse, poor body image, depression, anxiety, abnormal hormone levels, inherited traits, inflammation and infection of the prostate or urethra, and worrying about premature ejaculation.

Request sample Copy Of Research Report: https://www.coherentmarketinsights.com/insight/request-sample/1956

Market Dynamics

Increasing launches of novel products for the treatment of premature ejaculation is expected to fuel the global premature ejaculation treatment market growth. For instance, in 2016, Regent Pacific Group Limited, a Hong Kong-based investment group, launched its product, Fortacin in the U.K. Fortacin is a topical spray, which contains low doses of two anesthetics - lidocaine and prilocaine and is indicated for the treatment of premature ejaculation. Furthermore, increasing prevalence of premature ejaculation due to unhealthy lifestyle and various factors such as depression and hormonal imbalance is expected to rise demand for premature ejaculation treatment drugs. For instance, according to the data published by National Center for BioDrug Type Information in 2016, around 25.8% of male in China are suffering from premature ejaculation.

Frequent launches and approvals of novel premature ejaculation treatment products is expected to drive growth of the market

Key players in the market are focusing on launching new products, which in turn is expected to aid in growth of the market. For instance, in 2012, Absorption Pharmaceuticals, LLC launched its Promescent, an over-the-counter lidocaine-based spray, indicated for premature ejaculation. Furthermore, in 2013, Absorption Pharmaceuticals, LLC received patent for its Promescent, for premature ejaculation (PE) from the U.S. Patent and Trademark Office. The launches of novel drugs, which are indicated for the treatment of premature ejaculation is expected to fuel growth of the global premature ejaculation treatment market in the near future.

Increasing strategic collaborations for development of new diagnostic tools is expected to propel the market growth

Key players in the market are involved in strategic collaborations for the development of premature ejaculation treatment drugs. For instance, in 2012, Ampio Pharmaceuticals, Inc. entered in a strategic agreement with Ethypharm S.A. for the manufacturing of Zertane, Ampio's drug indicated for the treatment of premature ejaculation. In 2013, Absorption Pharmaceuticals LLC entered into a strategic collaboration with Kaiser Permanente for initiating clinical trial to evaluate the efficacy of Promescent lidocaine spray for men with premature ejaculation (PE). Such strategic collaborations by key players for the development, manufacturing, and evaluation of novel drugs is expected to fuel the global premature ejaculation treatment market growth.

Detailed Segmentation:

Global Premature Ejaculation Treatment Market, By Drug Type :

Selective Serotonin Reuptake Inhibitors (SSRIs)

Dapoxetine

Others

Phosphodiesterase Type 5 (PDE5) Inhibitors

Zertane

Others

Topical Anesthetics

Others

Global Premature Ejaculation Treatment Market, By Route of Administration:

Oral

Topical

Global Premature Ejaculation Treatment Market, By Dosage Form:

Pills

Spray

Others

Request for Customization: https://www.coherentmarketinsights.com/insight/request-customization/1956

Key Players:

Regent Pacific Group Limited

Menarini Group

Furiex Pharmaceuticals Inc.

Absorption Pharmaceuticals

LLC

Ampio PharmaceuticalsInc.

Aytu BioScience

NeuroHealing Pharmaceuticals Inc.

Dong-A Pharmaceutical Co. Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

[omarkhanca]

deep learning > Neurohive Digest - Искусственный интеллект, нейронные сети, deep learning | 2018-07-30T14:43:42.000Z